MyCardia™ is engineered using induced pluripotent stem cells (iPSCs), which were recognized with the Nobel Prize in Physiology or Medicine (2012).
MyCardia™ behaves like cardiac tissue and mimics key molecular attributes of the heart. MyCardia™ is comprised of multiple cell types. Each provides a unique therapeutic role that synergistically repairs the heart.
MyCardia™ is the future of regenerative medicine for the heart. MyCardia™ stimulates the body's repair mechanisms to grow new blood vessels and results in development of new cardiac tissue in treated areas.